A Recombinant Live Attenuated Strain of Vibrio cholerae Induces Immunity against Tetanus Toxin and Bordetella pertussis Tracheal Colonization Factor

Infection and Immunity

Volumn 66, Issue 4, 1998, Pages 1648-1653

  Chen, Inês ^a,b   Finn, Theresa M ^c   Yanqing, Liu ^d   Guoming, Qi ^d   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a  

^a CHIRON VACCINES   (Italy)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BORDETELLA VIRULENCE FACTOR; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; TETANUS TOXIN; TETANUS TOXIN FRAGMENT C; TRACHEAL COLONIZATION FACTOR, BORDETELLA PERTUSSIS;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MOUSE; PHYSIOLOGY; VIBRIO CHOLERAE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TETANUS TOXIN; VIBRIO CHOLERAE; VIRULENCE FACTORS, BORDETELLA;

EID: 0032039011     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.4.1648-1653.1998     Document Type: Article

References (37)

1. Acheson, D. W., M. M. Levine, J. B. Kaper, and G. T. Keusch. 1996. Protective immunity to Shiga-like toxin I following immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. Infect. Immun. 64:355-357.
2. Barry, E. M., O. Gomez-Duarte, S. Chatfield, R. Rappuoli, M. Pizza, G. Losonsky, J. Galen, and M. M. Levine. 1996. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD908. Infect. Immun. 64:4172-4181.
3. Betley, M. J., V. L. Miller, and J. J. Mekalanos. 1986. Genetics of bacterial enterotoxins. Annu. Rev. Microhiol. 40:577-605.
4. Butterton, J. R., D. T. Beattie, C. L. Gardel, P. A. Carroll, T. Hyman, K. P. Killeen, J. J. Mekalanos, and S. B. Calderwood. 1995. Heterologous antigen expression in Vibrio cholerae vector strains. Infect. Immun. 63:2689-2696.
5. Butterton, J. R., E. T. Ryan, R. A. Shahin, and S. B. Calderwood. 1996. Development of a germfree mouse model of Vibrio cholerae infection. Infect. Immun. 64:4373-4377.
6. Butterton, J. R., E. T. Ryan, D. W. K. Acheson, and S. B. Calderwood. 1997. Coexpression of the B subunit of shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect. Immun. 65:2127-2135.
7. Camilli, A., and J. Mekalanos. 1995. Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol. Microbiol. 18:671-683.
8. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains; development of a single-dose oral tetanus vaccine. Bio/ Technology 10:888-892.
9. Coster, T. S., K. P. Killeen, M. K. Waldor, D. T. Beattie, D. R. Spriggs, J. R. Kenner, A. Trofa, J. C. Sadoff, J. J. Mekanalos, and D. N. Taylor. 1995. Safety, immunogenicity and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345:949-952.
10. Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domeneghini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92:1644-1648.
11. Douce, G., M. R. Fontana, M. Pizza, R. Rappuoli, and G. Dougan. 1997. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 65:2821-2828.
12. Fairweather, N. F., V. A. Lyness, D. J. Pickard, G. Allen, and R. O. Thompson. 1986. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55:2541-2545.
13. Inaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide. Infect. Immun. 64:576-584.
14. Filip, C., G. Fletcher, J. L. Wulff, and C. F. Earhart. 1973. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol. 115:717-722.
15. Finn, T. M., and L. A. Stevens. 1995. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 16:625-634.
16. Galen, J. E., G. Gomez-Duarte, G. A. Losonsky, J. L. Halpern, C. S. Lauderbaugh, X. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intransal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708.
17. Goldberg, M. B., S. A. Bokyo, and S. B. Calderwood. 1991. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:1125-1129.
18. Helting, T. B., and O. Zwisler. 1977. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. J. Biol. Chem. 252:194-198.
19. Hopkins, S., J.-P. Kraehenbuhl, F. Schodel, A. Potts, D. Peterson, P. De Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
20. Ishibashi, Y., S. Claus, and D. A. Relman. 1994. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180:1225-1233.
21. Jones, D. H., B. W. McBride, C. Thornton, D. T. O'Hagan, A. Robinson, and G. H. Farrar. 1996. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. Infect. Immun. 64:489-494.
22. Langermann, S., S. Palaszynski, A. Sadziene, C. K. Stover, and S. Koenig. 1994. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372:552-555.
23. Leiniger, E., C. A. Ewanovich, A. Bhargava, M. S. Peppler, J. G. Kenimer, and M. J. Brennan. 1992. Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect. Immun. 60:2380-2385.
24. Levine, M. M., R. E. Black, M. L. Clements, L. Cisneros, D. R. Nalin, and C. R. Young. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
25. Levine, M. M., J. B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C. O. Tacket, B. Tall, and S. Cryz. 1988. Safety, immunogenicity and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet ii:467-470.
26. Liu, Y. Q., G. M. Qi, S. X. Xang, Y. M. Yu, G. C. Duan, L. J. Zhang, and S. Y. Gao. 1995. A natural vaccine candidate strain against cholera. Biomed. Environ. Sci. 8:350-358.
27. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
28. Owen, R. L., N. F. Pierce, R. T. Apple, and W. C. Cray, Jr. 1986. M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J. Infect. Dis. 153:1108-1118.
29. Oxer, M. D., C. M. Bentley, J. G. Doyle, I. G. Charles, and A. J. Makoff. 1991. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucleic Acids Res. 19:2889-2892.
30. Pearson, G. D., V. J. DiRita, M. B. Goldberg, S. A. Bokyo, S. B. Calderwood, and J. J. Mekalanos. 1990. New attenuated derivatives of Vibrio cholerae. Res. Microbiol. 141:893-899.
31. Pearson, G. D. N., and J. J. Mekalanos. 1982. Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K12. Proc. Natl. Acad. Sci. USA 79:2976-2980.
32. Redhead, K., J. Watkins, A. Barnard, and K. H. G. Mills. 1993. Effective immunity against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
33. Richardson, S. H. 1994. Animal models in cholera research, p. 203-206. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.). Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
34. Stainer, D. W., and M. J. Scholte. 1971. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.
35. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD1 12 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
36. Viret, J. F., S. J. Cryz, and D. Favre. 1996. Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae. Mol. Microbiol. 19:949-963.
37. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, M. Yamamoto, K. Fujihashi, F. W. van Ginkel, M. Noda, Y. Takeda, and J. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-typc responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267-5272.